199 related articles for article (PubMed ID: 33914397)
1. Performance, clinical effectiveness, and safety of immunoadsorption in a wide range of indications.
Fuchs K; Rummler S; Ries W; Helmschrott M; Selbach J; Ernst F; Morath C; Gauly A; Atiye S; Stauss-Grabo M; Giefer M
Ther Apher Dial; 2022 Feb; 26(1):229-241. PubMed ID: 33914397
[TBL] [Abstract][Full Text] [Related]
2. Peptide based adsorbers for therapeutic immunoadsorption.
Rönspeck W; Brinckmann R; Egner R; Gebauer F; Winkler D; Jekow P; Wallukat G; Müller J; Kunze R
Ther Apher Dial; 2003 Feb; 7(1):91-7. PubMed ID: 12921122
[TBL] [Abstract][Full Text] [Related]
3. Immunoadsorption with regenerating systems in neurological disorders --A single center experience.
Hohenstein B; Passauer J; Ziemssen T; Julius U
Atheroscler Suppl; 2015 May; 18():119-23. PubMed ID: 25936315
[TBL] [Abstract][Full Text] [Related]
4. Immunoadsorption can improve cardiac function in transplant candidates with non-ischemic dilated cardiomyopathy associated with diabetes mellitus.
Dandel M; Englert A; Wallukat G; Riese A; Knosalla C; Stein J; Hetzer R
Atheroscler Suppl; 2015 May; 18():124-33. PubMed ID: 25936316
[TBL] [Abstract][Full Text] [Related]
5. [Immunoadsorption for treatment of dilated cardiomyopathy].
Felix SB; Dörr M; Herda LR; Beug D; Staudt A
Internist (Berl); 2008 Jan; 49(1):51-6. PubMed ID: 18071664
[TBL] [Abstract][Full Text] [Related]
6. Effects of protein A immunoadsorption in patients with advanced chronic dilated cardiomyopathy.
Doesch AO; Konstandin M; Celik S; Kristen A; Frankenstein L; Hardt S; Goeser S; Kaya Z; Katus HA; Dengler TJ
J Clin Apher; 2009; 24(4):141-9. PubMed ID: 19591221
[TBL] [Abstract][Full Text] [Related]
7. The effect of a repeated immunoadsorption in patients with dilated cardiomyopathy after recurrence of severe heart failure symptoms.
Reinthaler M; Empen K; Herda LR; Schwabe A; Rühl M; Dörr M; Felix SB
J Clin Apher; 2015 Aug; 30(4):217-23. PubMed ID: 25346275
[TBL] [Abstract][Full Text] [Related]
8. Immunoadsorption in neurological disorders.
Oji S; Nomura K
Transfus Apher Sci; 2017 Oct; 56(5):671-676. PubMed ID: 28919008
[TBL] [Abstract][Full Text] [Related]
9. Treatment of chronic dilated cardiomyopathy with immunoadsorption using the staphylococcal A-agarose column: a comparison of immunoglobulin reduction using two different techniques.
Burgstaler EA; Cooper LT; Winters JL
J Clin Apher; 2007; 22(4):224-32. PubMed ID: 17610291
[TBL] [Abstract][Full Text] [Related]
10. Intravenous immunoglobulin application following immunoadsorption: benefit or risk in patients with autoimmune diseases?
Schmaldienst S; Müllner M; Goldammer A; Spitzauer S; Banyai S; Hörl WH; Derfler K
Rheumatology (Oxford); 2001 May; 40(5):513-21. PubMed ID: 11371659
[TBL] [Abstract][Full Text] [Related]
11. Endomyocardial proteomic signature corresponding to the response of patients with dilated cardiomyopathy to immunoadsorption therapy.
Bhardwaj G; Dörr M; Sappa PK; Ameling S; Dhople V; Steil L; Klingel K; Empen K; Beug D; Völker U; Felix SB; Hammer E
J Proteomics; 2017 Jan; 150():121-129. PubMed ID: 27616206
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of different immunoadsorption columns for anti-A/B antibody depletion.
Speer C; Kälble F; Pego da Silva L; Nusshag C; Schaier M; Becker LE; Klein K; Beimler J; Sommerer C; Leo A; Süsal C; Mehrabi A; Zeier M; Morath C
Atheroscler Suppl; 2019 Dec; 40():68-72. PubMed ID: 31447215
[TBL] [Abstract][Full Text] [Related]
13. Treatment of severe neurological deficits with IgG depletion through immunoadsorption in patients with Escherichia coli O104:H4-associated haemolytic uraemic syndrome: a prospective trial.
Greinacher A; Friesecke S; Abel P; Dressel A; Stracke S; Fiene M; Ernst F; Selleng K; Weissenborn K; Schmidt BM; Schiffer M; Felix SB; Lerch MM; Kielstein JT; Mayerle J
Lancet; 2011 Sep; 378(9797):1166-73. PubMed ID: 21890192
[TBL] [Abstract][Full Text] [Related]
14. Immunoadsorption in patients with dilated cardiomyopathy.
Herda LR; Felix SB; Staudt A
Atheroscler Suppl; 2009 Dec; 10(5):126-8. PubMed ID: 20129390
[TBL] [Abstract][Full Text] [Related]
15. Current topics on immunoadsorption therapy.
Nakaji S
Ther Apher; 2001 Aug; 5(4):301-5. PubMed ID: 11724516
[TBL] [Abstract][Full Text] [Related]
16. Post-Transplantation Immunoadsorption Can Be Withheld in ABO-Incompatible Kidney Transplant Recipients.
de Weerd AE; van Agteren M; Ijzermans JN; Weimar W; Betjes MG
Ther Apher Dial; 2015 Oct; 19(5):513-7. PubMed ID: 26219347
[TBL] [Abstract][Full Text] [Related]
17. Immunoadsorption in dilated cardiomyopathy.
Dörffel WV; Wallukat G; Baumann G; Felix SB
Ther Apher; 2000 Jun; 4(3):235-8. PubMed ID: 10910026
[TBL] [Abstract][Full Text] [Related]
18. Ig-Therasorb immunoadsorption for selective removal of human immunoglobulins in diseases associated with pathogenic antibodies of all classes and IgG subclasses, immune complexes, and fragments of immunoglobulins.
Koll RA
Ther Apher; 1998 May; 2(2):147-52. PubMed ID: 10225717
[TBL] [Abstract][Full Text] [Related]
19. Use of Cardiac Biomarkers for Monitoring Improvement of Left Ventricular Function by Immunoadsorption Treatment in Dilated Cardiomyopathy.
Weinmann K; Werner J; Koenig W; Rottbauer W; Walcher D; Keßler M
Biomolecules; 2019 Oct; 9(11):. PubMed ID: 31731547
[TBL] [Abstract][Full Text] [Related]
20. Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy.
Staudt A; Böhm M; Knebel F; Grosse Y; Bischoff C; Hummel A; Dahm JB; Borges A; Jochmann N; Wernecke KD; Wallukat G; Baumann G; Felix SB
Circulation; 2002 Nov; 106(19):2448-53. PubMed ID: 12417541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
